Rosalinda Roselli
Naples, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: September 20, 2024
Analysis of Oral and Gut Microbiota Composition in Children with Dental Caries by NGS Approaches.
Journal: Recent advances in inflammation & allergy drug discovery
Published: June 03, 2024
BAR502/fibrate conjugates: synthesis, biological evaluation and metabolic profile.
Journal: Frontiers in chemistry
Published: April 30, 2024
Defective Bile Acid Signaling Promotes Vascular Dysfunction, Supporting a Role for G-Protein Bile Acid Receptor 1/Farnesoid X Receptor Agonism and Statins in the Treatment of Nonalcoholic Fatty Liver Disease.
Journal: Journal of the American Heart Association
Published: November 24, 2023
Activation of GPBAR1 attenuates vascular inflammation and atherosclerosis in a mouse model of NAFLD-related cardiovascular disease.
Journal: Biochemical pharmacology
Published: August 29, 2023
Expanding the Library of 1,2,4-Oxadiazole Derivatives: Discovery of New Farnesoid X Receptor (FXR) Antagonists/Pregnane X Receptor (PXR) Agonists.
Journal: Molecules (Basel, Switzerland)
Published: March 02, 2023
Combinatorial therapy with BAR502 and UDCA resets FXR and GPBAR1 signaling and reverses liver histopathology in a model of NASH.
Journal: Scientific reports
Published: October 25, 2022
Beneficial effects of UDCA and norUDCA in a rodent model of steatosis are linked to modulation of GPBAR1/FXR signaling.
Journal: Biochimica et biophysica acta. Molecular and cell biology of lipids
Published: June 17, 2022
Combinatorial targeting of G-protein-coupled bile acid receptor 1 and cysteinyl leukotriene receptor 1 reveals a mechanistic role for bile acids and leukotrienes in drug-induced liver injury.
Journal: Hepatology (Baltimore, Md.)
Published: June 14, 2022
Modeling Inflammatory Bowel Disease by Intestinal Organoids.
Journal: Recent advances in inflammation & allergy drug discovery
Published: May 27, 2022
Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Journal: Frontiers in oncology
Published: May 09, 2022
Last Updated: 09/26/2026